MedPath

The effect of the combination of dimenhydrinate with metoclopramide and dimenhydrinate with ondansetron with dimenhydrinate alone in the prevention of nausea and vomiting after the surgery

Phase 3
Conditions
Z98.4
Cataract surgery.
Cataract extraction status
Registration Number
IRCT20200825048515N9
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
160
Inclusion Criteria

Candidates for cataract surgery
American Society of Anesthesiologists (ASA) physical status classification system equal I, II, and III
Stability of patients' hemodynamic status

Exclusion Criteria

History of motor disease
Smoking or addicted patients
Patients with allergies to the studied drugs
Liver and vestibular disorders
Taking anti-nausea drugs in the past 24 hours
Prolongation of surgery more than 45 minutes.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity of nausea. Timepoint: At the time of discharge from recovery and 2 and 4 hours after leaving recovery. Method of measurement: Visual Analogue Scale.;Severity of vomiting. Timepoint: At the time of discharge from recovery and 2 and 4 hours after leaving recovery. Method of measurement: Visual Analogue Scale.;Pain. Timepoint: 1 hour after surgery. Method of measurement: Visual Analogue Scale.;Patient satisfaction. Timepoint: When referring to the ward. Method of measurement: Visual Analogue Scale.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath